Picton Mahoney Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1K | Sell |
11
-269
| -96% | -$24.5K | ﹤0.01% | 811 |
|
|
2025
Q1 | $34K | Buy |
280
+269
| +2,445% | +$32.7K | ﹤0.01% | 450 |
|
|
2024
Q4 | $1K | Sell |
11
-95
| -90% | -$8.64K | ﹤0.01% | 680 |
|
|
2024
Q3 | $11K | Buy |
+106
| New | +$11K | ﹤0.01% | 505 |
|
|
2023
Q3 | – | Sell |
-635
| Closed | -$79K | – | 429 |
|
|
2023
Q2 | $79K | Sell |
635
-20
| -3% | -$2.49K | ﹤0.01% | 310 |
|
|
2023
Q1 | $96K | Sell |
655
-210
| -24% | -$30.8K | ﹤0.01% | 361 |
|
|
2022
Q4 | $138K | Sell |
865
-55
| -6% | -$8.78K | 0.01% | 504 |
|
|
2022
Q3 | $122K | Sell |
920
-100
| -10% | -$13.3K | ﹤0.01% | 538 |
|
|
2022
Q2 | $159K | Sell |
1,020
-965
| -49% | -$150K | 0.01% | 615 |
|
|
2022
Q1 | $309K | Sell |
1,985
-4,635
| -70% | -$722K | 0.01% | 632 |
|
|
2021
Q4 | $843K | Sell |
6,620
-27,320
| -80% | -$3.48M | 0.02% | 597 |
|
|
2021
Q3 | $4.42M | Sell |
33,940
-1,320
| -4% | -$172K | 0.16% | 135 |
|
|
2021
Q2 | $6.27M | Buy |
35,260
+690
| +2% | +$123K | 0.18% | 95 |
|
|
2021
Q1 | $5.68M | Sell |
34,570
-8,360
| -19% | -$1.37M | 0.27% | 101 |
|
|
2020
Q4 | $7.09M | Buy |
+42,930
| New | +$7.09M | 0.34% | 89 |
|